STERIS plc $STE Stock: Danske Bank A S Reduces Stake

Danske Bank A S decreased its stake in STERIS plc (NYSE:STE – Free Report) by 6.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 50,110 shares of the medical equipment provider’s stock after selling 3,400 shares during the quarter. Danske Bank A S owned 0.05% of STERIS worth $10,524,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of STE. Western Wealth Management LLC bought a new stake in shares of STERIS in the 1st quarter valued at about $25,000. Compass Financial Management LLC bought a new position in STERIS during the 3rd quarter worth approximately $25,000. Elevation Wealth Partners LLC boosted its stake in STERIS by 1,130.0% during the 2nd quarter. Elevation Wealth Partners LLC now owns 123 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 113 shares during the last quarter. Trust Co. of Vermont acquired a new position in STERIS during the second quarter valued at approximately $41,000. Finally, Community Financial Services Group LLC grew its holdings in STERIS by 50.0% during the third quarter. Community Financial Services Group LLC now owns 216 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 72 shares during the period. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently weighed in on STE. Jefferies Financial Group raised shares of STERIS from a “hold” rating to a “buy” rating and lifted their price target for the stock from $232.00 to $305.00 in a research report on Friday, November 13th. Weiss Ratings upgraded STERIS from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, November 9th. UBS Group decreased their target price on STERIS from $275.00 to $270.00 and set a “buy” rating for the company in a research note on Friday, August 7th. KeyCorp increased their price target on STERIS from $269.00 to $284.00 and gave the stock an “overweight” rating in a report on Friday, November 6th. Finally, Morgan Stanley raised STERIS from an “overweight” rating to a “buy” rating in a research report on Friday, November 13th. Five analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $283.50.

View Our Latest Stock Report on STERIS

Insider Activity at STERIS

In other STERIS news, Director Mohsen Sohi sold 4,893 shares of the business’s stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $253.22, for a total value of $1,239,005.46. Following the sale, the director owned 24,305 shares in the company, valued at approximately $6,154,512.10. The trade was a 16.76% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Julia Madsen sold 2,046 shares of the company’s stock in a transaction that occurred on Friday, November 13th. The stock was sold at an average price of $260.00, for a total value of $531,960.00. Following the transaction, the vice president directly owned 10,211 shares of the company’s stock, valued at approximately $2,654,860. This trade represents a 16.69% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 12,819 shares of company stock valued at $3,274,011. 1.12% of the stock is owned by insiders.

STERIS Trading Up 0.9%

STE opened at $259.66 on Thursday. The stock has a market capitalization of $25.22 billion, a P/E ratio of 23.64 and a beta of 0.86. STERIS plc has a 12 month low of $195.14 and a 12 month high of $269.44. The firm’s fifty day simple moving average is $225.69 and its 200 day simple moving average is $224.58. The company has a current ratio of 2.05, a quick ratio of 1.44 and a debt-to-equity ratio of 0.23.

STERIS (NYSE:STE – Get Free Report) last released its earnings results on Wednesday, November 4th. The medical equipment provider reported $2.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.68 by $0.26. STERIS had a return on equity of 14.80% and a net margin of 13.41%. The firm had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter in the prior year, the company earned $2.47 EPS. The company’s revenue was up 8.8% on a year-over-year basis. As a group, research analysts anticipate that STERIS plc will post 11.46 EPS for the current fiscal year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Tuesday, November 17th will be issued a dividend of $0.69 per share. The ex-dividend date is Tuesday, November 17th. This represents a $2.76 dividend on an annualized basis and a dividend yield of 1.1%. STERIS’s dividend payout ratio (DPR) is presently 32.74%.

STERIS Profile

(Free Report)

STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.

Featured Articles

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.